Baseline | 1 week | 1 month | 6 months | CV % | ICC# | |
Healthy adults n | 40 | 40 | 40 | 38 | ||
LCI | 6.94±0.61 | 7.09±0.64 | 7.12±0.74 | 7.05±0.66 | 4.4±3.0 | 0.71 |
FRCMBW L | 3.21±0.81 | 3.03±0.76 | 2.97±0.73 | 2.92±0.71 | 7.7±6.6 | 0.82 |
Scond L−1 | 0.028±0.026 | 0.026±0.020 | 0.021±0.017 | 0.028±0.029 | 72.9±41.8 | 0.44 |
Scond×VT | 0.029±0.029 | 0.027±0.024 | 0.023±0.019 | 0.028±0.030 | 73.1±41.9 | 0.62 |
Sacin L−1 | 0.058±0.028 | 0.058±0.029 | 0.057±0.039 | 0.055±0.041 | 48.7±78.2 | 0.42 |
Sacin×VT | 0.060±0.034 | 0.065±0.036 | 0.058±0.037 | 0.058±0.041 | 44.4±34.4 | 0.52 |
dN2 % N2 per L | 0.99±0.42 | 1.03±0.43 | 1.23±0.68 | 1.10±0.46 | 16.4±16.5 | 0.80 |
dN2×VC % N2 | 3.82±1.36 | 3.81±1.27 | 4.26±1.73 | 4.04±1.31 | 14.1±11.9 | 0.84 |
SIIIDTG g·mol−1·L−1 | −0.206±0.108 | −0.195±0.089 | −0.205±0.109 | −0.216±0.121 | 22.2±31.4 | 0.80 |
SIIIDTG×VT g·mol−1 | −0.204±0.091 | −0.199±0.089 | −0.201±0.096 | −0.212±0.110 | 20.7±30.5 | 0.82 |
AUC g·%·mol−1 | 16.40±5.38 | 16.87±5.37 | 17.18±5.88 | 17.17±6.27 | 17.5±52.5 | 0.93 |
COPD patients n | 20 | 19 | 17 | 15 | ||
LCI | 12.23±2.67 | 12.40±3.48 | 12.07±2.88 | 12.42±2.62 | 5.3±5.4 | 0.89 |
FRCMBW L | 4.19±1.27 | 4.30±1.00 | 4.13±1.23 | 4.20±1.66 | 5.9±5.8 | 0.87 |
Scond L−1 | 0.045±0.034 | 0.042±0.031 | 0.050±0.035 | 0.047±0.032 | 45.1±32.0 | 0.67 |
Scond×VT | 0.046±0.034 | 0.045±0.031 | 0.048±0.033 | 0.043±0.029 | 29.8±22.4 | 0.66 |
Sacin L−1 | 0.343±0.139 | 0.330±0.143 | 0.348±0.153 | 0.384±0.156 | 16.3±15.8 | 0.86 |
Sacin×VT | 0.355±0.150 | 0.354±0.160 | 0.367±0.167 | 0.354±0.162 | 8.8±8.5 | 0.87 |
dN2 % N2 per L | 7.43±5.38 | 7.40±4.01 | 7.44±4.00 | 7.17±3.41 | 7.8±5.7 | 0.81 |
dN2×VC % N2 | 20.60±6.84 | 22.01±7.92 | 22.18±7.49 | 21.46±6.80 | 7.1±5.1 | 0.83 |
SIIIDTG g·mol−1·L−1 | −0.653±0.428 | −0.635±0.419 | −0.721±0.447 | −0.820±0.459 | 10.1±9.0 | 0.95 |
SIIIDTG×VT g·mol−1 | −0.630±0.344 | −0.601±0.325 | −0.664±0.305 | −0.726±0.353 | 9.6±9.8 | 0.96 |
AUC g·%·mol−1 | 33.07±18.59 | 32.32±18.36 | 24.50±18.46 | 25.43±20.18 | 7.9±14.1 | 0.97 |
Data are presented as mean±sd unless otherwise stated. Intra-visit reproducibility was assessed as distribution (mean±sd) of the intraindividual coefficient of variation (CV) of three single measurements of all subjects and all test occasions. ICC: intraclass correlation coefficient; LCI: lung clearance index; FRCMBW: functional residual capacity measured by nitrogen multiple-breath washout; Scond: index of conductive ventilation inhomogeneity; VT: tidal volume; Sacin: index of acinar ventilation inhomogeneity; dN2: phase III slope of nitrogen single-breath washout; VC: vital capacity; SIIIDTG: phase III slope of double tracer gas single-breath washout; AUC: area under the curve (double tracer gas single-breath washout). #: calculated from three individual trials on the same day.